September 6, 2024
A potential first-in-class therapy for migraine prevention has shown promise in a phase 2a proof-of-concept study, with a single infusion reducing migraine frequency over 4 weeks. […]
September 6, 2024
Living in areas saturated with artificial outdoor light at night is associated with an increased risk for Alzheimer’s disease (AD), a new national study suggested. Analyses […]
September 5, 2024
TOPLINE: A history of migraine is not associated with an elevated risk for Parkinson’s disease (PD) in women, regardless of headache frequency or migraine subtype, a […]
September 3, 2024
(Reuters) -Athira Pharma said on Tuesday its drug failed to meet the main goal in a mid-to-late stage trial in patients with mild-to-moderate Alzheimer’s disease. The […]
August 28, 2024
If you encourage patients coming back from stroke to exercise, you’re doing the right thing. Regular physical activity can help improve recovery and reduce the risk […]
August 26, 2024
Advocacy groups for patients with neurologic disorders have become a common feature in the landscape of drug and device development and federal research funding allocation. On […]
August 23, 2024
TOPLINE: There is no link between the COVID-19 vaccination and an increased risk for multiple sclerosis (MS) relapse in most patients. However, there is a small […]
August 22, 2024
TOPLINE: Older adults with untreated hypertension have a 36% increased risk for Alzheimer’s disease (AD) compared with those without hypertension and a 42% increased risk for […]
August 22, 2024
(Reuters) -Alzheimer’s patients in Britain’s state-run health service are unlikely to get access to Eisai and Biogen’s new Leqembi drug, after it was approved on Thursday […]